These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 15257859)

  • 21. [Angiotensin II receptor blockers: current status and future prospects].
    Corvol P; Plouin PF
    Drugs; 2002; 62 Spec No 1():53-64. PubMed ID: 12036389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal responses to angiotensin receptor antagonist and angiotensin-converting enzyme inhibitor in partially nephrectomized spontaneously hypertensive rats.
    Okada H; Suzuki H; Kanno Y; Ikenaga H; Saruta T
    J Cardiovasc Pharmacol; 1995 Oct; 26(4):564-9. PubMed ID: 8569216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The pathophysiologic role of the brain renin-angiotensin system in stroke protection: clinical implications.
    Chrysant SG
    J Clin Hypertens (Greenwich); 2007 Jun; 9(6):454-9. PubMed ID: 17541331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal responses to AT1 receptor blockade.
    Navar LG; Harrison-Bernard LM; Imig JD; Cervenka L; Mitchell KD
    Am J Hypertens; 2000 Jan; 13(1 Pt 2):45S-54S. PubMed ID: 10678288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of the angiotensin II Type 1 receptor by TCV-116: quantitation by in vitro autoradiography.
    Song K; Kanehara H; Takai S; Shiota N; Wada T; Inada Y; Miyazaki M
    Jpn J Pharmacol; 1999 Feb; 79(2):131-9. PubMed ID: 10202848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pathophysiological mechanisms of the renin-angiotensin system and its pharmacologic modification by ACE inhibitors or angiotensin II (type 1) receptor blockers in cardiovascular diseases].
    Huber K; Pachinger O; Pichler M; Klein W
    Z Kardiol; 1997 Apr; 86(4):239-50. PubMed ID: 9235795
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glomerular losartan (DuP 753)-sensitive angiotensin II receptor density is increased in young spontaneously hypertensive rats.
    Haws RM; Shaul PW; Arant BS; Atiyeh BA; Seikaly MG
    Pediatr Res; 1994 Jun; 35(6):671-6. PubMed ID: 7936816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blockade of the renin-angiotensin system in heart failure in conscious dogs.
    Murakami M; Suzuki H; Naitoh M; Matsumoto A; Kageyama Y; Tsujimoto G; Saruta T
    J Hypertens; 1995 Dec; 13(12 Pt 1):1405-12. PubMed ID: 8866902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure.
    Levy BI; Benessiano J; Henrion D; Caputo L; Heymes C; Duriez M; Poitevin P; Samuel JL
    J Clin Invest; 1996 Jul; 98(2):418-25. PubMed ID: 8755652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro.
    Kojima M; Shiojima I; Yamazaki T; Komuro I; Zou Z; Wang Y; Mizuno T; Ueki K; Tobe K; Kadowaki T
    Circulation; 1994 May; 89(5):2204-11. PubMed ID: 8181146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ACE inhibition and AT1 receptor blockade prevent fatty liver and fibrosis in obese Zucker rats.
    Toblli JE; Muñoz MC; Cao G; Mella J; Pereyra L; Mastai R
    Obesity (Silver Spring); 2008 Apr; 16(4):770-6. PubMed ID: 18239590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood pressure lowering and renin-angiotensin system blockade.
    Unger T
    J Hypertens Suppl; 2003 Jul; 21(6):S3-7. PubMed ID: 14513945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new class of therapeutic agents: the angiotensin II receptor antagonists.
    Timmermans PB; Smith RD
    Cardiologia; 1994 Dec; 39(12 Suppl 1):397-400. PubMed ID: 7634303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiotensin II receptor blockade: an innovative approach to cardiovascular pharmacotherapy.
    Eberhardt RT; Kevak RM; Kang PM; Frishman WH
    J Clin Pharmacol; 1993 Nov; 33(11):1023-38. PubMed ID: 8300885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Production of angiotensin II by homogeneous cultures of vascular smooth muscle cells from spontaneously hypertensive rats.
    Fukuda N; Satoh C; Hu WY; Soma M; Kubo A; Kishioka H; Watanabe Y; Izumi Y; Kanmatsuse K
    Arterioscler Thromb Vasc Biol; 1999 May; 19(5):1210-7. PubMed ID: 10323771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of angiotensin II receptors in stroke protection.
    Chrysant SG
    Curr Hypertens Rep; 2012 Jun; 14(3):202-8. PubMed ID: 22447068
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of AT1 receptor blockade on renal injury and mitogen-activated protein activity in Dahl salt-sensitive rats.
    Nishiyama A; Yoshizumi M; Rahman M; Kobori H; Seth DM; Miyatake A; Zhang GX; Yao L; Hitomi H; Shokoji T; Kiyomoto H; Kimura S; Tamaki T; Kohno M; Abe Y
    Kidney Int; 2004 Mar; 65(3):972-81. PubMed ID: 14871417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is the angiotensin II Type 2 receptor cerebroprotective?
    Fournier A; Achard JM; Boutitie F; Mazouz H; Mansour J; Oprisiu R; Fernandez L; Messerli F
    Curr Hypertens Rep; 2004 Jun; 6(3):182-9. PubMed ID: 15128469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic actions of angiotensin receptor antagonists: PPAR-gamma agonist actions or a class effect?
    Ernsberger P; Koletsky RJ
    Curr Opin Pharmacol; 2007 Apr; 7(2):140-5. PubMed ID: 17303473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interactions between the renin-angiotensin system (RAS) and the sympathetic system.
    Dendorfer A; Raasch W; Tempel K; Dominiak P
    Basic Res Cardiol; 1998; 93 Suppl 2():24-9. PubMed ID: 9833158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.